Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 12,478,497
- Share change
- -650,271
- Total reported value
- $28,076,000
- Price per share
- $2.25
- Number of holders
- 15
- Value change
- -$1,746,455
- Number of buys
- 5
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
4.6%
|
5,940,796
|
$16,100,000 | — | 31 Mar 2021 | |
| TPG Group Holdings (SBS) Advisors, Inc. |
13F
|
Company |
3.8%
|
4,824,883
|
$13,075,000 | — | 31 Mar 2021 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.99%
|
1,263,408
|
$3,424,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
0.45%
|
576,500
|
$1,574,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.1%
|
133,215
|
$361,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
121,849
|
$330,000 | — | 31 Mar 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
109,600
|
$299,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
49,077
|
$133,000 | — | 31 Mar 2021 | |
| WealthTrust Axiom LLC |
13F
|
Company |
0.03%
|
38,500
|
$104,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.03%
|
32,394
|
$87,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
11,414
|
$31,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
10,617
|
$29,000 | — | 31 Mar 2021 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
10,000
|
$27,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,378
|
$6,000 | — | 31 Mar 2021 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
1,900
|
$5,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,237
|
$3,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 31 Mar 2021 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q2 2021
As of 30 Jun 2021,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,478,497 shares.
The largest 10 holders included
NEA Management Company, LLC, TPG Group Holdings (SBS) Advisors, Inc., Omega Fund Management, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., WealthTrust Axiom LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and Alberta Investment Management Corp.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
17
Q2 2021 holders
15
Holder diff
-2
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.